Scleroderma News reports The Scleroderma Foundation has awarded eight research grants for projects seeking to advance personalized medicine, new therapeutic targets, and more, in the field of scleroderma research.

HSS rheumatologist Kimberly Showalter, MD received a three-year grant to determine if fibroblasts - a key cell type in scleroderma that produces collagen — can help predict clinical improvement in response to treatment. Ultimately, this may help offer treatment to people more likely to benefit, and spare from toxic effects those unlikely to improve.

Read the full article at Sclerodermanews.com.